Contrasting Oncolytics Biotech (ONCYF) and Its Competitors

Contrasting Oncolytics Biotech (ONCYF) and Its Competitors


Oncolytics Biotech is one of 525 publicly-traded companies in the "Pharmaceutical preparations" industry, but how does it compare to its rivals? We will compare Oncolytics Biotech to related businesses based on the strength of its profitability, valuation, analyst recommendations, dividends, earnings, risk and institutional ownership. Oncolytics Biotech has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога